1 |
Yu H, Guan F, Miller H, Lei J, Liu C. The role of SARS-CoV-2 nucleocapsid protein in antiviral immunity and vaccine development. Emerg Microbes Infect 2023;12:e2164219. [PMID: 36583642 DOI: 10.1080/22221751.2022.2164219] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
2 |
Jurenka J, Nagyová A, Dababseh M, Mihalov P, Stankovič I, Boža V, Kravec M, Palkovič M, Čaprnda M, Sabaka P. Anti-SARS-CoV-2 Antibody Status at the Time of Hospital Admission and the Prognosis of Patients with COVID-19: A Prospective Observational Study. Infect Dis Rep 2022;14:1004-16. [PMID: 36547246 DOI: 10.3390/idr14060100] [Reference Citation Analysis]
|
3 |
Vu LD, Wallace S, Phan AT, Christofferson RC, Turner E, Parker S, Elkind-Hirsch K, Landry D, Stansbury A, Rose R, Nolan DJ, Lamers SL, Hirezi M, Ogden B, Cormier SA. Absence of antibody responses to SARS-CoV-2 N protein in COVID-19 vaccine breakthrough cases. Exp Biol Med (Maywood) 2022;247:1923-36. [PMID: 36408542 DOI: 10.1177/15353702221134097] [Reference Citation Analysis]
|
4 |
Duarte LF, Vázquez Y, Diethelm-varela B, Pavez V, Berríos-rojas R, White JA, Kalergis AM, Bueno SM, González PA. DIFFERENTIAL SARS-COV-2 ANTIGEN SPECIFICITY OF THE HUMORAL RESPONSE IN INACTIVATED VIRUS-VACCINATED, CONVALESCENT, AND BREAKTHROUGH SUBJECTS.. [DOI: 10.1101/2022.07.01.22277165] [Reference Citation Analysis]
|